Amber Masse, NP
Family · Idaho Falls, IDNPI 1235208687
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 84.7% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2021 at $11,050 and has fallen 95.4% since, to $510 in 2025. Among family clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 246 payments — averaging $68.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$14K
- Medtronic$490
- Astellas Pharma US Inc$461
- Scynexis, Inc.$346
- Lilly USA, LLC$262
- Axsome Therapeutics, Inc.$217
- plus $780 from 18 others
What the payments were for
- Speaking & faculty fees$9,34656%
- Travel & lodging$3,21319%
- Food & beverage$3,87723%
- Education$3112%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 156 | $14,192 |
| Medtronic | 5 | $490 |
| Astellas Pharma US Inc | 15 | $461 |
| Scynexis, Inc. | 1 | $346 |
| Lilly USA, LLC | 21 | $262 |
| Axsome Therapeutics, Inc. | 11 | $217 |
| AstraZeneca | 3 | $168 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $111 |
| Novo Nordisk | 4 | $108 |
| Teva Pharmaceuticals USA, Inc. | 4 | $91 |
| Exeltis, USA Inc. | 3 | $44 |
| Amgen | 2 | $36 |
| Pfizer | 2 | $32 |
| Novartis | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Urovant Sciences Inc | 1 | $22 |
| Coopersurgical, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Abbott | 1 | $17 |
| Millicent US Inc | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
| Mayne Pharma Commercial LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,747 in reported general payments places this provider in the 95th percentile of 809 family providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 33 | $616 |
| Zolpidem Tartrate | 19 | $365 |
| Levothyroxine Sodium | 30 | $215 |
| Omeprazole | 24 | $141 |
| Escitalopram Oxalate | 12 | $117 |
| Simvastatin | 18 | $48 |
| Hydrochlorothiazide | 14 | $19 |
Paid to pharmacies, not to this prescriber.
Other family in Idaho Falls
- Samantha de Bruyn KopsIdaho Falls$10K
- Paula SanderlinIdaho Falls$10K
- Sunita SigdelIdaho Falls$9K
- Melissa KellyIdaho Falls$7K
- Kelsi RoundsIdaho Falls$6K
- Daniel HuntingIdaho Falls$6K
- Sunny RaichartIdaho Falls$5K
- Derek WhitmillIdaho Falls$5K
- Malinda McReaIdaho Falls$5K
- Jonathan WilliamsIdaho Falls$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.